Luís Masmiquel

4.3k total citations · 1 hit paper
15 papers, 589 citations indexed

About

Luís Masmiquel is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Luís Masmiquel has authored 15 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Luís Masmiquel's work include Diabetes Treatment and Management (6 papers), Pharmacology and Obesity Treatment (3 papers) and Phytase and its Applications (3 papers). Luís Masmiquel is often cited by papers focused on Diabetes Treatment and Management (6 papers), Pharmacology and Obesity Treatment (3 papers) and Phytase and its Applications (3 papers). Luís Masmiquel collaborates with scholars based in Spain, Denmark and United Kingdom. Luís Masmiquel's co-authors include Julie Derving Karsbøl, Mehmet Sargın, Francis Chun Chung Chow, Harish Kumar, Bo Åhrén, Pilar Sanchís, F. Gráses, Regina Fortuny, Antonia Costa‐Bauzá and Miquel Adrover and has published in prestigious journals such as Scientific Reports, The American Journal of Medicine and Journal of Hypertension.

In The Last Decade

Luís Masmiquel

14 papers receiving 582 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

2017 368 citations Bo Åhrén, Luís Masmiquel et al. The Lancet Diabetes & Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luís Masmiquel Spain	9	421	296	109	97	56	15	589
Shuting Yang China	11	146 0.3×	157 0.5×	72 0.7×	72 0.7×	47 0.8×	30	401
Hideyuki Kabasawa Japan	11	85 0.2×	176 0.6×	65 0.6×	35 0.4×	17 0.3×	34	553
M Nesović Serbia	14	281 0.7×	79 0.3×	63 0.6×	19 0.2×	63 1.1×	36	582
Hua Jiang China	14	60 0.1×	183 0.6×	115 1.1×	33 0.3×	27 0.5×	47	508
Anandharajan Rathinasabapathy United States	11	121 0.3×	182 0.6×	72 0.7×	28 0.3×	30 0.5×	29	605
Toshiki Hozumi Japan	10	157 0.4×	117 0.4×	88 0.8×	19 0.2×	14 0.3×	19	337
Xinwen Yu China	10	97 0.2×	167 0.6×	41 0.4×	27 0.3×	19 0.3×	31	475
Andreas Melidonis Greece	10	112 0.3×	92 0.3×	92 0.8×	37 0.4×	13 0.2×	16	444
Alessia Frisina Italy	8	185 0.4×	140 0.5×	55 0.5×	20 0.2×	23 0.4×	9	729
Yoichi Tachi Japan	13	63 0.1×	95 0.3×	50 0.5×	71 0.7×	79 1.4×	22	577

Countries citing papers authored by Luís Masmiquel

Since Specialization

Citations

This map shows the geographic impact of Luís Masmiquel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Masmiquel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Masmiquel more than expected).

Fields of papers citing papers by Luís Masmiquel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Masmiquel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Masmiquel. The network helps show where Luís Masmiquel may publish in the future.

Co-authorship network of co-authors of Luís Masmiquel

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Masmiquel. A scholar is included among the top collaborators of Luís Masmiquel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Masmiquel. Luís Masmiquel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sanchís, Pilar, et al.. (2023). Phytate Intake, Health and Disease: “Let Thy Food Be Thy Medicine and Medicine Be Thy Food”. Antioxidants. 12(1). 146–146. 42 indexed citations

Tofé, Santiago, Iñaki Argüelles, Cristina Álvarez, et al.. (2023). Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study. European Thyroid Journal. 12(3). 2 indexed citations

Sanchís, Pilar, et al.. (2023). Daily phytate intake increases adiponectin levels among patients with diabetes type 2: a randomized crossover trial. Nutrition and Diabetes. 13(1). 2–2. 19 indexed citations

Torrens‐Mas, Margalida, Catalina Crespı́, Aina M. Galmés‐Panades, et al.. (2022). GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Frontiers in Cellular and Infection Microbiology. 12. 942951–942951. 5 indexed citations

Sanchís, Pilar, Regina Fortuny, Carlos Río, et al.. (2020). Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 9(6). 1751–1751. 10 indexed citations

Sanchís, Pilar, Regina Fortuny, Miquel Adrover, et al.. (2018). Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial. Scientific Reports. 8(1). 9619–9619. 50 indexed citations

Leiter, Lawrence A., G. Charpentier, Louis Chaykin, et al.. (2017). Semaglutide Reduces Body Weight Across Baseline BMI Subgroups Across SUSTAIN 1–5. Canadian Journal of Diabetes. 41(5). S6–S6. 8 indexed citations

Åhrén, Bo, Luís Masmiquel, Harish Kumar, et al.. (2017). Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial. The Lancet Diabetes & Endocrinology. 5(5). 341–354. 368 indexed citations breakdown →

Martínez, José María Gámez, Luís Masmiquel, Tomás Ripoll, Vivencio Barrios, & Manuel Anguita. (2016). Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischaemic heart disease: Data from the SIRENA study. Diabetes Research and Clinical Practice. 123. 82–86. 3 indexed citations

10.

Masmiquel, Luís, Lawrence A. Leiter, Josép Vidal, et al.. (2016). LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovascular Diabetology. 15(1). 29–29. 42 indexed citations

11.

Petrie, John R., Steven P. Marso, Stephen C. Bain, et al.. (2016). LEADER-4. Journal of Hypertension. 34(6). 1140–1150. 15 indexed citations

12.

Sanchís, Pilar, C. Françès, Joana Nicolau, et al.. (2014). Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up. Obesity Surgery. 25(1). 97–108. 12 indexed citations

13.

Nicolau, Joana, et al.. (2014). Spinal epidural abscess in a diabetic patient. Endocrinología y Nutrición (English Edition). 61(4). 224–226. 1 indexed citations

14.

Masmiquel, Luís. (2013). Efectos cardiovasculares y seguridad de los fármacos hipoglucemiantes: situación actual. Medicina de Familia SEMERGEN. 40(2). 80–88. 2 indexed citations

15.

Masmiquel, Luís, et al.. (1993). Adrenal abscess as a complication of adrenal fine-needle biopsy. The American Journal of Medicine. 95(2). 244–245. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact